Add Yahoo as a preferred source to see more of our stories on Google. UCLA scientists created AlloCAR70-NKT, a ready-to-use immune cell therapy that targets kidney cancer from multiple angles—without ...

Metastatic kidney survival rates don’t predict individual outcomes. A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival.

Natural killer cells, also referred to as NK cells, play several major roles in the body's defense against cancers like renal cell carcinoma. Natural killer cells, also referred to as NK cells, play ...

The University of New Mexico Cancer Center recently enrolled its first patient in a phase 3 international clinical trial to test a personalized vaccine against metastatic kidney cancer. Kidney cancer ...

New research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans Affairs has identified the molecular mechanism that causes kidney ...

Many medicines are available to treat kidney cancer. If one treatment doesn’t help or stops working, your health care provider may recommend another option. If you or a loved one has kidney cancer and ...

Kidney cancer is a disease where cancer cells begin to develop abnormally in the kidneys. As cancer cells grow rapidly, they can form a tumor, and eventually, the cancer can spread to other parts of ...

What is Kidney Cancer? The kidneys play a crucial role in filtering blood in our body. However, sometimes abnormal cells can ...

A kidney cancer survivor shares how a decade of breakthroughs in immunotherapy and targeted research transformed a death ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...